In the first phase of the study, participants in the acute phase of COVID-19 presented patterns of elevated inflammation in the form of high concentrations of cytokines such as TNF (TNF–α), LTA (TNF–β), IL–1β, IL–4, IL–6, IL–8, IL–13, and interferon (IFN) –α2. The gene discussed is IL13; the disease is COVID-19.